GILD - Gilead Sciences, Inc.
IEX Last Trade
78.98
-0.470 -0.595%
Share volume: 6,204,270
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$79.45
-0.47
-0.59%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-02 | 2023-02-22 | 2023-05-03 | 2023-08-04 | 2023-11-07 | 2024-02-23 | 2024-05-08 | |
| Total revenue | 6.260 B | 7.042 B | 7.389 B | 6.352 B | 6.599 B | 7.050 B | 7.115 B | 6.686 B | |
| Cost of revenue | 1.442 B | 1.395 B | 1.396 B | 1.401 B | 1.442 B | 1.565 B | 2.090 B | 1.552 B | |
| Gross profit | 4.818 B | 5.647 B | 5.993 B | 4.951 B | 5.157 B | 5.485 B | 5.025 B | 5.134 B | |
| 17.21% | 6.13% | -17.39% | 4.16% | 6.36% | -8.39% | 2.17% | |||
| Operating expenses | 2.459 B | 2.362 B | 3.560 B | 2.766 B | 3.256 B | 2.772 B | 3.014 B | 2.895 B | |
| Selling general and admin | 1.357 B | 1.213 B | 2.020 B | 1.319 B | 1.849 B | 1.315 B | 1.607 B | 1.375 B | |
| Research and development | 1.102 B | 1.149 B | 1.540 B | 1.447 B | 1.407 B | 1.457 B | 1.407 B | 1.520 B | |
| Total expenses | 3.901 B | 3.757 B | 4.956 B | 4.167 B | 4.698 B | 4.337 B | 5.104 B | 4.447 B | |
| -3.69% | 31.91% | -15.92% | 12.74% | -7.68% | 17.69% | -12.87% | |||
| Operating income | 2.359 B | 3.285 B | 2.433 B | 2.185 B | 1.901 B | 2.713 B | 2.011 B | 2.239 B | |
| Ebit | 2.359 B | 3.285 B | 2.433 B | 2.185 B | 1.901 B | 2.713 B | 2.011 B | 2.239 B | |
| Pretax income | 1.503 B | 2.432 B | 2.031 B | 1.300 B | 1.587 B | 2.318 B | 1.654 B | -4.485 B | |
| 61.81% | -16.49% | -35.99% | 22.08% | 46.06% | -28.65% | -371.16% | |||
| Income tax | 368.000 M | 646.000 M | 398.000 M | 316.000 M | 549.000 M | 146.000 M | 236.000 M | -315.000 M | |
| Net income basic | 1.144 B | 1.789 B | 1.640 B | 1.010 B | 1.045 B | 2.180 B | 1.429 B | -4.170 B | |
| 56.38% | -8.33% | -38.41% | 3.47% | 108.61% | -34.45% | -391.81% | |||
| Net income | 1.144 B | 1.789 B | 1.640 B | 1.010 B | 1.045 B | 2.180 B | 1.429 B | -4.170 B | |
| 56.38% | -8.33% | -38.41% | 3.47% | 108.61% | -34.45% | -391.81% |